Patents by Inventor Juhani Janne

Juhani Janne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for the treatment and prevention of pancreatitis and for induction of liver regeneration
    Patent number: 7202280
    Abstract: Novel methods for treating and preventing acute and/or chronic pancreatitis are described. Additionally, novel methods for inducing liver regeneration are described. The methods may comprise administering to a patient an effective amount of a metabolically stable analogue of spermidine and/or spermine. Preferred compounds for use in the methods may include 1-methylspermidine, 1-methylspermine and 1,12-dimethylspermine.
    Type: Grant
    Filed: December 9, 2003
    Date of Patent: April 10, 2007
    Inventors: Tiina-Liisa Räsänen, Leena Alhonen, Riitta Sinervirta, Tuomo Keinänen, Karl-Heinz Herzig, Alex Radii Khomutov, Jouko Vepsäläinen, Juhani Jänne
  • Methods for the treatment and prevention of pancreatitis and for induction of liver regeneration
    Publication number: 20040180968
    Abstract: Novel methods for treating and preventing acute and/or chronic pancreatitis are described. Additionally, novel methods for inducing liver regeneration are described. The methods may comprise administering to a patient an effective amount of a metabolically stable analogue of spermidine and/or spermine. Preferred compounds for use in the methods may include 1-methylspermidine, 1-methylspermine and 1,12-dimethylspermine.
    Type: Application
    Filed: December 9, 2003
    Publication date: September 16, 2004
    Inventors: Tiina-Liisa Rasanen, Leena Alhonen, Riitta Sinervirta, Tuomo Keinanen, Karl-Heinz Herzig, Alex Radii Khomutov, Jouko Vepsalainen, Juhani Janne
  • Method for the production of biologically active polypeptides in a mammal's
    Patent number: 5959171
    Abstract: A process is disclosed for the production of a protein or polypeptide in the milk of a transgenic non-human mammal where the protein or polypeptide is produced as fusion protein with another protein. The fusion protein can then be cleaved to release the protein or polypeptide. This method would reduce or prevent the formation of side effects associated with ectopic expression or leakage of the protein or polypeptide. Such a fusion protein is .beta.-lactoglobulin-EPO, where biologically active EPO is released upon cleavage of the fusion protein.
    Type: Grant
    Filed: August 17, 1994
    Date of Patent: September 28, 1999
    Assignee: Pharming B.V.
    Inventors: Juha-Matti Hyttinen, Veli-Pekka Korhonen, Juhani Janne